# US 2011/0236926 A1 · Host Cells and Methods Of Producing Disulfide Bond Containing Proteins

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2011/0236926 A1
- Document ID: US20110236926A1
- Status: Published application
- Kind: A1
- Application number: 12/934,631
- Filed: 2009-03-24
- Published: 2011-09-29
- Earliest claimed: 2008-03-26
- Assignees: Danisco US Inc.
- Inventors: Jean-Yves Francois Dubois; Roelof Hendrik Matthijs Kouwen; Jan Maarten Van Dijl
- Web page: https://patentgrep.com/patent/US20110236926A1

## CPC

- C12N 15/67: General methods for enhancing the expression
- C12N 9/0036: {acting on NADH or NADPH (1.6)}
- C12N 15/75: for Bacillus
- C12P 21/02: having a known sequence of two or more amino acids, e.g. glutathione
- C12Y 108/01008: Protein-disulfide reductase (1.8.1.8), i.e. thioredoxin
- C12Y 108/01009: Thioredoxin-disulfide reductase (1.8.1.9), i.e. thioredoxin-reductase
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- C12Y: ENZYMES

## Abstract

The invention provides for genetically modified Bacillus host cells having decreased cytoplasmic reductase activity, such as decreased TrxA activity, and a nucleic acid encoding a heterologous Staphylococcal oxidase. The invention also provides for methods of producing di-sulfide bond containing proteins using the host cells of the invention and methods of improving protein folding using the host cell of the invention.

## Claims

### Claim 1

A genetically modified Bacillus host cell comprising i) a genetic modification to decrease activity of a cytoplasmic reductase in the host cell, and ii) a nucleic acid sequence encoding a heterologous staphylococcal oxidase or mutant thereof that retains oxidase activity.

### Claim at position 2

2-11. (canceled)

### Claim 12 (depends on 1)

A culture of the host cells of claim 1.

### Claim 13 (depends on 12)

The culture of claim 12, wherein the culture is grown in a medium containing a redox-active compound.

### Claim 14 (depends on 13)

The culture of claim 13, wherein the redox-active compound is selected from the group consisting of cysteine, cystine, glutathione, 2-mercaptoethanol (BME), 1,4-dithiothreitol (DTT), thiosulfate, dithionite, metabisulfite, sulfite, N-ethylmaleimide or mycothiol.

### Claim 15 (depends on 1)

The genetically modified Bacillus host cell of claim 1,
wherein the cytoplasmic reductase is a TrxA polypeptide comprising the amino acid sequence of SEQ ID NO:2, and the heterologous staphylococcal oxidase is a DbsA polypeptide comprising the amino acid sequence of SEQ ID NO:4.

### Claim 16 (depends on 1)

The host cell of claim 1 further comprising a nucleic acid sequence encoding a disulfide bond containing protein.

### Claim 17

(canceled)

### Claim 18

A method of producing a disulfide bond containing protein in a Bacillus host cell comprising
i) decreasing activity of a cytoplasmic reductase in the host cell
ii) introducing a nucleic acid sequence encoding a heterologous staphylococcal oxidase or mutant thereof that retains oxidase activity in the host cell wherein the oxidase is from a nondisease-causing Staphylococcus bacterium, and
iii) growing the host cell in media containing a redox-active compound, wherein the host cell produces the disulfide bond containing protein and secretes the protein into the media.

### Claim 19 (depends on 18)

The method of claim 18, wherein the cytoplasmic reductase is a TrxA polypeptide.

### Claim 20 (depends on 19)

The method of claim 19, wherein the TrxA polypeptide is selected from the group consisting of:
i) an amino acid sequence of SEQ ID NO:2,
ii) an amino acid sequence encoded by the nucleic acid sequence of SEQ ID NO:1,
iii) an amino acid sequence that is at least 90% identical to the amino acid sequence of SEQ ID NO:2,
iv) an amino acid sequence encoded by a nucleic acid sequence that is at least 90% identical to the nucleic acid sequence of SEQ ID NO:1, and
v) an amino acid sequence encoded by a nucleic acid sequence that hybridizes under stringent conditions to the complement of SEQ ID NO:1.

### Claim 21 (depends on 18)

The method of claim 18, wherein the oxidase is introduced by transforming the host cell with a plasmid comprising a nucleic acid sequence encoding the oxidase.

### Claim 22 (depends on 18)

The method of claim 18, wherein the oxidase is a DsbA polypeptide.

### Claim 23 (depends on 22)

The method of claim 22, wherein the DsbA polypeptide is selected from the group consisting of:
i) an amino acid sequence of SEQ ID NO:4,
ii) an amino acid sequence encoded by the nucleic acid sequence of SEQ ID NO:3
iii) an amino acid sequence that is at least 90% identical to the amino acid sequence of SEQ ID NO:4,
iv) an amino acid sequence encoded by a nucleic acid sequence that is at least 90% identical to the nucleic acid sequence of SEQ ID NO:3, and
v) an amino acid sequence encoded by a nucleic acid sequence that hybridizes under stringent conditions to the complement of SEQ ID NO:3.

### Claim 24 (depends on 18)

The method of claim 18, wherein the host cell is Bacillus subtilis.

### Claim 25 (depends on 18)

The method of claim 18, wherein the nondisease-causing Staphylococcus bacterium is Staphylococcus carnosus.

### Claim 26 (depends on 18)

The method of claim 18, wherein the decrease in cytoplasmic reductase activity is caused by mutation in a cytoplasmic reductase gene.

### Claim 27 (depends on 26)

The method of claim 26, wherein the mutation is a deletion mutation, substitution mutation or insertion mutation.

### Claim 28 (depends on 18)

The method of claim 18, wherein the decreased cytoplasmic reductase activity is controlled by an inducible promoter.

### Claim 29 (depends on 18)

The method of claim 18, wherein the redox-active compound is selected from the group consisting of cysteine, cystine, glutathione, 2-mercaptoethanol (BME), 1,4-dithiothreitol (DTT), thiosulfate, dithionite, metabisulfite, sulfite, N-ethylmaleimide or mycothiol.

### Claim 30 (depends on 18)

The method of claim 18, wherein the cytoplasmic reductase is a TrxA polypeptide comprising the amino acid sequence of SEQ ID NO:2; and the oxidase is a DsbA polypeptide comprising the amino acid sequence of SEQ ID NO:4.

### Claim 31

A method of improving protein folding of a recombinant protein comprising
a) growing a genetically modified Bacillus host cell in media containing a redox-active compound, under conditions that permit expression of and improve proper folding of a disulfide bond containing protein, wherein said host cell (i) exhibits decreased cytoplasmic reductase activity and (ii) exhibits increased expression of a heterologous staphylococcal oxidase, or mutant thereof that retains oxidase activity, and (iii) secretes a heterologous disulfide bond containing protein; and
b) optionally, isolating said protein from the media.

### Claim at position 23

32-42. (canceled)
